Description
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide consisting of nine amino acids. It has been studied for several decades because of its possible involvement in sleep regulation and other processes within the nervous and endocrine systems.
Research has primarily examined DSIP in relation to sleep architecture, sleep onset and the regulation of normal sleep-wake patterns. Studies have also explored possible interactions with stress-related hormonal signalling, including the hypothalamic-pituitary-adrenal (HPA) system.
In plain English: researchers became interested in DSIP because it appears to be connected with the way the body regulates sleep. Rather than acting like a conventional sedative, research has looked at whether it may influence the body’s own sleep mechanisms, potentially affecting how easily sleep begins and how efficiently normal sleep is maintained.
Small human studies have produced mixed results. Some early trials reported improvements in measures such as sleep efficiency, sleep duration or the time taken to fall asleep, while other controlled studies found the effects to be relatively small and of uncertain clinical importance. Research into DSIP remains limited, and it has not been established as a proven treatment for insomnia or other sleep disorders.
Supplied by Black Knight Peptides for laboratory and research purposes only.
Not for human consumption.
